51 studies found for:    autoinflammatory
Show Display Options
Rank Status Study
21 Recruiting Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
Conditions: Cryopyrin-associated Periodic Syndromes (CAPS);   Familial Cold Autoinflam Syn (FCAS);   Muckle-wells Syn (MWS);   Neonatal Onset Multisystem Inflam Disease (NOMID)
Intervention:
22 Recruiting The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
23 Recruiting Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers
Condition: Hereditary Periodic Fevers
Interventions: Drug: canakinumab;   Drug: Placebo
24 Recruiting The Rifaximin Study in CVID
Condition: Common Variable Immunodeficiency (CVID)
Intervention: Drug: Rifaximin
25 Recruiting Genetic and Functional Analysis of Cherubism
Condition: Cherubism
Intervention:
26 Active, not recruiting Ilaris® Effects in Schnitzler Syndrome (ILESCH)
Condition: Schnitzler Syndrome
Interventions: Drug: Canakinumab;   Drug: Placebo
27 Unknown  Canakinumab for Pyoderma Gangrenosum
Condition: Pyoderma Gangrenosum
Intervention: Drug: Canakinumab
28 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
29 Completed Efficacy and Safety of Canakinumab in Schnitzler Syndrome
Condition: Schnitzler Syndrome
Intervention: Drug: Canakinumab
30 Recruiting Cold Contact Urticaria Treatment With Rilonacept
Condition: Cold Contact Urticaria
Interventions: Drug: Rilonacept;   Drug: Placebo
31 Recruiting Anakinra for Inflammatory Pustular Skin Diseases
Condition: Pustular Dermatosis
Intervention: Drug: Anakinra
32 Recruiting Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis
Intervention: Drug: Interleukin 2
33 Completed Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
Condition: Familial Mediterranean Fever
Intervention: Drug: colchicine sprinkle capsules
34 Completed Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS)
Condition: TNF-receptor Associated Periodic Syndromes (TRAPS)
Intervention: Drug: ACZ885
35 Withdrawn Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
Condition: Familial Mediterranean Fever
Intervention:
36 Recruiting Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
Condition: Familial Mediterranean Fever,
Intervention: Drug: Kineret
37 Unknown  Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients
Condition: Familial Mediterranean Fever
Intervention:
38 Not yet recruiting Association Between Basal Proteinuria Levels and Pregnancy Outcomes in Familial Mediterranean Fever
Condition: Basal Proteinuria in Pregnancy
Intervention:
39 Enrolling by invitation Heat Intolerance in the Group of FMF Patients
Conditions: Familial Mediterranean Fever;   Heat Intolerance;   Heat Tolerance Test
Intervention:
40 Completed Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean Fever
Condition: Familial Mediterranean Fever
Intervention: Drug: Canakinumab

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results
Indicates status has not been verified in more than two years